Sign In
Buy HCAT
$2.09
+0.0100 (+0.481%)
At Close: Jul 31, 2026
CyncHealth Selects Health Catalyst to Elevate Health Data Management
04:05pm, Wednesday, 06'th Nov 2024
SALT LAKE CITY , Nov. 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, tod
Health Catalyst Signs Definitive Agreement to Acquire Top-Rated Cybersecurity Provider, Intraprise Health
04:05pm, Wednesday, 06'th Nov 2024
SALT LAKE CITY , Nov. 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, to
Nationally Recognized Healthcare Executive Dr. Jill Hoggard Green Joins Health Catalyst Board of Directors
04:05pm, Wednesday, 06'th Nov 2024
SALT LAKE CITY , Nov. 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, tod
Health Catalyst Reports Third Quarter 2024 Results
04:03pm, Wednesday, 06'th Nov 2024
SALT LAKE CITY, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizati
Health Catalyst (HCAT) Upgraded to Buy: Here's What You Should Know
01:01pm, Tuesday, 08'th Oct 2024
Health Catalyst (HCAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets
10:34am, Tuesday, 24'th Sep 2024
I recommend a buy rating for Health Catalyst stock. HCAT's Ignite platform is gaining traction, offering modular solutions that enhance adoption, cross-sell opportunities, and expand the total address
Health Catalyst to Participate in Upcoming Investor Conferences
04:05pm, Tuesday, 27'th Aug 2024
SALT LAKE CITY, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
WISHIN Expands Relationship with Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe™ Suite
08:00am, Tuesday, 27'th Aug 2024
SALT LAKE CITY , Aug. 27, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, to
Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon
08:00am, Thursday, 08'th Aug 2024
SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, to
Health Catalyst Announces Partnership Expansion with Western U.S.'s Largest Health Information Exchange, Contexture
08:00am, Thursday, 08'th Aug 2024
SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, tod
Health Catalyst and South Dakota Health Link Expand Partnership to Improve the Quality and Effectiveness of Healthcare in the Midwest
08:00am, Thursday, 08'th Aug 2024
SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, to
Health Catalyst, Inc. (HCAT) Q2 2024 Earnings Call Transcript
10:39pm, Wednesday, 07'th Aug 2024
Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Jack Knight - VP, IR Dan Burton - CEO & Director Dan LeSueur - COO Jason Alger - CF
Health Catalyst (HCAT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
08:36pm, Wednesday, 07'th Aug 2024
The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street e
Health Catalyst (HCAT) Tops Q2 Earnings and Revenue Estimates
08:05pm, Wednesday, 07'th Aug 2024
Health Catalyst (HCAT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago.
Health Catalyst Reports Second Quarter 2024 Results
04:13pm, Wednesday, 07'th Aug 2024
SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
